PLEASE READ: Communication through the Internet, through this Website, and through Email does NOT create an attorney-client relationship with Harman Law LLC. Do not assume that your communications are privileged or confidential. Before accepting a new client, the Rules of Professional Conduct require us to determine whether there are any existing or potential conflicts of interest with any of our current or previous clients. Any communication with Harman Law LLC should be considered informational only and should not be relied or acted upon until a formal attorney-client relationship is established through a signed written fee agreement entered into with an attorney.
Harman Law LLC is a national law firm that fights for justice for those who have been harmed – physically, emotionally, or financially – by a company that refuses to do what’s right.
Matthew S. Harman is the
founder of Harman Law LLC.
A graduate of Harvard Law School, Mr. Harman handles high-stakes cases across the country in the pharmaceutical, medical device, energy, automotive, healthcare, chemical, consumer products, and telecommunications industries.
Mr. Harman is known for his capacity to tackle complex issues, his ability to communicate with jurors, and for his high-energy determination to obtain success for his clients. He is a frequent writer and lecturer on a variety of legal topics. Atlanta Magazine has named him to its list of “Rising Stars” in the legal community.
Most Recent Experience:
Litigating in the Pennsylvania Mass Tort Program (“MTP”) in which hundreds of parents claim that ingestion of a medication during the first trimester of pregnancy produced birth defects in their children. He was a member of the trial team of the first case tried in that MTP, against one of the most recognizable trial lawyers from the state of Texas.
Winning a complete reversal of a $27 million jury verdict in a dram shop case brought against his client arising from an accident involving multiple fatalities and quadriplegia. After three years on appeal — with interest pushing the judgment over $40 million — the South Carolina Supreme Court issued a unanimous opinion in Mr. Harman’s client’s favor.
Winning a complete reversal of a $80 million jury verdict in a Medicaid fraud case brought by the state of Alabama.
Litigating in the federal multi-district litigation (“MDL”) of in the Southern District of New York in which a dietary supplement caused thousands of people to suffer from serious side effects, including strokes, heart attacks, and sudden death.
Publications and Speaking Engagements:
“Enemy of the State: The Challenges of Civil Litigation with States and Municipalities,” ABA Section of Litigation Annual Conference, Atlanta, Georgia, April 2009.
“Vicarious Liability: Theory & Practice,” Petroleum Marketing Attorneys’ Annual Conference, Washington, D.C., April 2008.
“E-Discovery In Healthcare Litigation: Information Management Strategies Under the New Federal Rules,” Teleconference by Legal Publishing Group of Strafford Publications, June 2007.
“Understanding the Amended Federal Rules of Civil Procedure: What Companies Need to Know,” Morgantown, West Virginia, May 2007.
“E-Discovery: What Healthcare Entities Need to Know Now,” Healthcare Roundtable, April 2007.
“First Steps on the Path to Production” and “E-Discovery Project Management and the Digital Evidence Triage Team,” West Legalworks E-Discovery A-Z Workshop, Atlanta, Georgia, April 2007.
Chairperson, Mealey’s Corporate E-Discovery Conference, Atlanta, Georgia, April 2007.
“The New Federal E-Discovery Rules: An Expository Narrative,” Metropolitan Corporate Counsel, March 2007.
“E-Discovery: What Healthcare Entities Need to Know Now,” Health and Law Policy Forum, March 2007.
“Compliant E-Discovery: The Technology Tools,” ARMA International 2006 Conference, San Antonio, Texas, October 2006.
“E-Discovery Projects and the Digital Evidence Triage Team,” “Review & Production of Electronic Documents,” and “Risk Management When Things Go Wrong: Learning from Common EDD Blunders,” West Legalworks E-Discovery: An A to Z Workshop, Atlanta, Georgia, October 2006.
“Maintaining Privileges Under the Federal Rules” and “E-Discovery and Document Retention Policies,” North Carolina Journal of Law & Technology Seminar, Ghost in the Machine: Emerging Issues in Electronic Discovery for North Carolina Business and Practitioners, Chapel Hill, North Carolina, October 2006.
“Being Proactive—Developing a Plan for Electronic Discovery,” Mealey’s Email Discovery & Retention Policies Conference, San Francisco, California, May 2006.
The Daubert standard of admissibility for expert testimony. Emory Law School, September 2005.
Education
Mr. Harman received his J.D. from Harvard Law School. He received a B.S. in Mathematics from the University of Kentucky, where he graduated summa cum laude and Phi Beta Kappa.
Admissions
Mr. Harman is admitted to practice in Georgia. He has been admitted pro hac vice in courts of Alabama, Florida, Illinois, Louisiana, North Carolina, Ohio, Pennsylvania, South Carolina, Tennessee, and West Virginia.
About Harman Law LLC
Harman Law LLC is a national law firm that fights for justice for those who have been harmed – physically or financially – by someone who refuses to do what’s right. Contact us today by filling out a questionnaire, or by calling our toll free number (1-888-554-4672) for a no-cost no-obligation preliminary evaluation of your case.
Harman Law filed a complaint and is continuing to pursue defendants on behalf of a child who developed leukemia specific to benzene exposure while living near a petroleum transport station. For years, the station used by BP, Chevron, Gulf and other oil companies illegally disposed of toxic material including benzene resulting in documented contamination of the ground near the family’s home and in their drinking water supply.
The complaint is filed in the Superior Court of Athens-Clarke County, Georgia by Harman Law LLC and Nidel Law PLLC of Washington, D.C.
Related information
J.M. as Parent and next friend of minor son J.M.M. v. BP Products North America Inc.; Chevron U.S. A. Inc.,; Gulf Oil Corporation; Union Oil Company of California; Transmontaigne Product Services, Inc.: Transmontaigne Product Services Inc. East; Louis Dreyfus Highbridge Energy LLC; Colonial Pipeline Company; and Plantation Pipe Line Company
From the CNN Atlanta studios, Attorney Matthew Harman appeared on the legal television program The American Law Journal discussing the U.S. Food and Drug Administration.
Parents of premature babies in a four-year study of oxygen level treatment were not sufficiently warned of the potential dangers of the experiments. The families of over one thousand babies could have been at risk of blindness, brain damage or death as a consequence of their participation in the research.
The U.S. Department of Health and Human Services criticized lead researchers at the nearly two dozen participating medical schools for inadequate informed consent. Emory University Medical School in Atlanta participated in the study.
The attorneys at Harman Law Firm are investigating any harm to babies that may have occurred during their involvement in the research. If you or a family you know has an infant who was in the study at Emory or any research center who experienced a health problem contact our firm immediately to learn your options and protect the child’s health in the future. Fill out our contact form, email info@harmanlaw.com, or call toll-free 888-554-2762.
Links
The Harman Law Firm has filed a complaint against the manufacturer of the Medtronic MiniMed Paradigm MMT 722 Insulin Pump following the death of a young woman who was using the device.
The MiniMed Insulin Pump is designed to deliver insulin continuously into the body, making multiple injections per day unnecessary. The young college student with the MiniMed pump died from “diabetic ketoacidosis,” a condition that results from uncontrolled blood sugar that can quickly lead to heart failure, kidney failure, coma or death.
The complaint alleges that the MiniMed pump was defective and malfunctioned and that the manufacturer tested the pump following the woman’s death and concluded that the pump was in fact defective with a “faulty microchip” and “broken solder on joint on the interface board.” The manufacturer’s testing also concluded that the pump was “unable to prime,” meaning it could not eliminate air in the system so that it could pump the correct amount of pure insulin.”
Attorney Matthew Harman and the firm’s associates are continuing to investigate injuries that may be a result of using any of Medtronic drug pump model, including the recalled SynchroMed II and SynchroMed EL in addition to the MiniMed Paradigm insulin pump. For more information, see this page on the recall of Medtronic drug pumps.
If you or someone you know has experienced harm from a Medtronic drug or insulin pump, contact us for a free, no obligation consultation to learn your rights. You may be entitled to compensation, though there may be a time limit to file a claim.
If you are currently experiencing any health-related issues, consult your medical professional immediately.
If you have a knee or hip implant, please contact us to see if you are entitled to compensation. Several makes and models have either been recalled or have had manufacturers issue warnings. Harman Law Firm is investigating and available for free, no obligation consultations.
This website is designed for general information only. The information contained on this site does not constitute legal advice and does not form an attorney-client relationship.
